Amplify Weight Loss Drug & Treatment ETF (THNR)
NYSEARCA: THNR · Real-Time Price · USD
23.11
+0.22 (0.98%)
At close: Jul 9, 2025, 4:00 PM
23.11
0.00 (0.00%)
After-hours: Jul 9, 2025, 4:10 PM EDT

THNR Holdings Information

THNR is an equity ETF with a total of 22 individual holdings. The top holdings are Eli Lilly and Company stock at 12.41%, Novo Nordisk at 11.01%, Regeneron Pharmaceuticals at 7.21%, Amgen at 6.90%, and Chugai Pharmaceutical at 6.34%.

Total Holdings
22
Top 10 Percentage
69.47%
Asset Class
Equity
ETF Category
Health
Assets
2.98M
PE Ratio
19.28

Sector Allocation

Top 25 Holdings

Jul 3, 2025
No.SymbolName WeightShares
1LLYEli Lilly and Company12.41%474
2NVONovo Nordisk A/S11.01%4,748
3REGNRegeneron Pharmaceuticals, Inc.7.21%393
4AMGNAmgen Inc.6.90%690
5TYO: 4519Chugai Pharmaceutical Co., Ltd.6.34%3,900
6PFEPfizer Inc.5.27%6,197
7GILDGilead Sciences, Inc.5.15%1,374
8MRKMerck & Co., Inc.5.10%1,881
9ABBVAbbVie Inc.5.08%800
10SWX: ROGRoche Holding AG4.98%459
11AZNAstraZeneca PLC4.78%2,052
12HKG: 1801Innovent Biologics, Inc.4.34%12,000
13TYO: 4507Shionogi & Co., Ltd.4.22%7,300
14HKG: 1093CSPC Pharmaceutical Group Limited3.80%108,000
15HIMSHims & Hers Health, Inc.3.50%2,175
16CPH: ZEALZealand Pharma A/S2.35%1,223
17VKTXViking Therapeutics, Inc.1.99%2,105
18CRNXCrinetics Pharmaceuticals, Inc.1.67%1,676
19AGPXXShort-Term Investment Trust - Invesco Government & Agency Portfolio1.63%48,673
20HKG: 3933The United Laboratories International Holdings Limited1.19%18,000
21KRX: 128940Hanmi Pharm. Co., Ltd.0.87%120
22n/aDEPOSITS WITH BROKER FOR SHORT POSITIONS0.19%82,817,637
As of Jul 3, 2025